In March 2025, the company introduced new programs for a direct-to-shopper supplying of its Wegovy weight loss drug. The company recognized a brand new pharmacy, termed NovoCare, which would charge buyers $499 a month for usage of the drug, fewer than half the expense of the drug via other pharmaceutical distribution networks.[53]Reports of Rybelsu